The EBRD is considering providing EUR 40 million loan to Sofia Med, a Bulgarian metal processing company specialized in copper and copper alloy products. EUR 30 million will be used for company’s work capital financing as a part of a larger balance sheet restructuring and EUR10 million will be used to finance energy efficiency measures and increase capacity for higher value products.
The Bank’s support, along with long-term commitments from commercial banks, will help the company operate with a sustainable long-term financing structure.
This will enable Sofia Med to embark on additional capital expenditures to increase efficiency and cut down production costs. , The investments will also help the company to shift production towards higher value-added products like high performance alloys and industrial rolled products). The planned energy efficiency projects and especially improved energy efficiency management system will bring the company in line with best international practices.
Given its importance for the Bulgarian economy, Sofia Med’s further development will also boost growth of its numerous up-stream and down-stream clients.
Sofia Med, the leading Bulgarian copper, titanium zinc and brass processor, is a joint-stock company incorporated 100% owned by Halcor, a large-scale metal processing company with over sixty years of experience. a . 95% of Sofia Med’s products is exported to Western and Eastern Europe.
EUR 40 million loan.
EUR 40 million loan.
The proposed project has been categorised B in accordance with the 2008 EBRD Environmental and Social Policy. The potential impacts are expected to be site specific and readily identifiable and addressed through mitigation measures.
The current operations of Sofia Med were reviewed and found to be in compliance with local, and therefore EU legal requirements and the related Integrated Pollution Prevention and Control permitting regime. The company's management capacity and practice meet standards that will allow for operations and future investment projects to be implemented in line with the EBRD's performance requirements.
The implementation and certification of quality, health and safety and environmental systems, coupled with significant modernisation of the plant undertaken with the International Financial Corporation’s involvement from 2001 to date, has resulted in the application of best practices to many aspects of the operations. Minor improvements in the hazardous waste storage area were discussed with the site management and will be reflected in the environmental and social action plan to be agreed with the company.
Sofia Med may potentially face requirements to purchase additional emission credits in the future. However, as a result of cooperation between the company and the EBRD teams for Environment and Sustainability and Energy Efficiency and Climate Change and based on the energy audit findings, a capital expenditure programme is being developed to support energy efficiency measures.
For business opportunities or procurement, contact the client company.
EBRD project enquiries not related to procurement:
Tel: +44 20 7338 7168
Public Information Policy (PIP)
The PIP sets out how the EBRD discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations. Please visit the Public Information Policy page below to find out how to request a Public Sector Board Report.
Text of the PIP
Project Complaint Mechanism (PCM)
The Project Complaint Mechanism (PCM) is the EBRD's accountability mechanism. It provides an opportunity for an independent review of complaints from individuals and organisations concerning EBRD-financed projects which are alleged to have caused, or are likely to cause, environmental and/or social harm.
Please visit the Project Complaint Mechanism page to find information about how to submit a complaint. The PCM Officer (firstname.lastname@example.org) is available to answer any questions you may have regarding the submission of a complaint and criteria for registration and eligibility, in accordance with the PCM Rules of Procedure.